tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
X4 Pharmaceuticals (XFOR)
:XFOR
US Market
XFOR
X4 Pharmaceuticals
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

X4 Pharmaceuticals (XFOR) Stock News & Sentiment

Compare
967 Followers
Strategic Restructuring and Market Opportunities Drive Buy Rating for X4 Pharmaceuticals
Premium
Ratings
Strategic Restructuring and Market Opportunities Drive Buy Rating for X4 Pharmaceuticals
15d ago
XFOR
X4 Pharmaceuticals Announces Strategic Restructuring Plans
Premium
Company Announcements
X4 Pharmaceuticals Announces Strategic Restructuring Plans
16d ago
8K
XFOR
X4 Pharmaceuticals Partners with Norgine for Mavorixafor Expansion
Premium
Company Announcements
X4 Pharmaceuticals Partners with Norgine for Mavorixafor Expansion
1M ago
8K
XFOR
X4 Pharmaceuticals Reports Positive Trial Results and Progress
Premium
Company Announcements
X4 Pharmaceuticals Reports Positive Trial Results and Progress
3M ago
XFOR
X4 Pharmaceuticals: Promising Phase 2 Trial Results
Premium
Company Announcements
X4 Pharmaceuticals: Promising Phase 2 Trial Results
3M ago
8K
XFOR
XFOR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
XFOR Earnings this Week: How Will it Perform?
3M ago
XFOR
X4 Pharmaceuticals Unveils Corporate Presentation for Investors
Premium
Company Announcements
X4 Pharmaceuticals Unveils Corporate Presentation for Investors
7M ago
8K
XFOR
More XFOR News >

XFOR News on the Web

X4 and taiba to distribute WHIM syndrome therapy in Middle East
Pharmaceutical Technology
Neutral
X4 Pharmaceuticals, Taiba to Distribute Xolremdi in Select Middle East Countries
Yahoo Finance
Neutral
X4 Pharmaceuticals and taiba rare Announce Exclusive Agreement for the Distribution and Commercialization of XOLREMDI® in WHIM Syndrome in Select Middle East Countries
Yahoo Finance
Neutral
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty
BioPharma Dive
Neutral
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia
Yahoo Finance
Neutral
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo Finance
Neutral
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application for Mavorixafor for the Treatment of WHIM Syndrome
Yahoo Finance
Neutral
January 2025's Top US Penny Stocks To Consider
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
XFOR
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XFOR’s Media Buzz Sentiment?
3 articles about XFOR were published this week. In an average week, 1.5 articles are published.
    What is XFOR’s weekly average amount of articles?
    In an average week, 1.5 articles about XFOR are published.
      What is XFOR’s News Sentiment?
      59% of articles about XFOR were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        SHGSingular Health Group Ltd
        RCUSArcus Biosciences
        HCMHUTCHMED
        PENPenumbra
        AMNAMN Healthcare Services
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing